CoChat

Sex differences in micro- and macro-vascular complications of diabetes mellitus

Maric-Bilkan, Christine · 2017 · Clinical Science

The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.

Abstract

Vascular complications are a leading cause of morbidity and mortality in both men and women with type 1 (T1DM) or type 2 (T2DM) diabetes mellitus, however the prevalence, progression and pathophysiology of both microvascular (nephropathy, neuropathy and retinopathy) and macrovascular [coronary heart disease (CHD), myocardial infarction, peripheral arterial disease (PAD) and stroke] disease are different in the two sexes. In general, men appear to be at a higher risk for diabetic microvascular complications, while the consequences of macrovascular complications may be greater in women. Interestingly, in the absence of diabetes, women have a far lower risk of either micro- or macro-vascular disease compared with men for much of their lifespan. Thus, the presence of diabetes confers greater risk for vascular complications in women compared with men and some of the potential reasons, including contribution of sex hormones and sex-specific risk factors are discussed in this review. There is a growing body of evidence that sex hormones play an important role in the regulation of cardiovascular function. While estrogens are generally considered to be cardioprotective and androgens detrimental to cardiovascular health, recent findings challenge these assumptions and demonstrate diversity and complexity of sex hormone action on target tissues, especially in the setting of diabetes. While some progress has been made toward understanding the underlying mechanisms of sex differences in the pathophysiology of diabetic vascular complications, many questions and controversies remain. Future research leading to understanding of these mechanisms may contribute to personalized- and sex-specific treatment for diabetic micro- and macro-vascular disease.

Overview

Integrity signals

Registry

Crossref · 10.1042/cs20160998

Cites

144 of 144 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 144 references

Research works printed but not linked: 2

  1. Brand, 1989, Diabetes, intermittent claudication, and risk of cardiovascular events, The Framingham Study. Diabetes, 38, 504
  2. Kanaya, 2003, Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/Progestin Replacement Study, A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med., 138, 1

Cited by

Items 101–200 of 221

Metadata

Authors
Maric-Bilkan, C.
Affiliations
Division of Cardiovascular Sciences, Vascular Biology and Hypertension Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, U.S.A.
Venue
Clinical Science
Published
2017-04-19
Volume
131
Issue
9
Pages
833-846
ISSN
  • 0143-5221 (ISSN-L)
  • 1470-8736
OpenAlex
W2605955340
Cited by
217
References
144
Citations by year
2026: 12 · 2025: 22 · 2024: 20 · 2023: 29 · 2022: 20 · 2021: 35 · 2020: 41 · 2019: 17 · 2018: 19 · 2017: 2
FWCI
3.51
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Science (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Sex and Gender in Healthcare
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
sex differences, diabetes mellitus, diabetic microvascular complications, diabetic macrovascular complications, diabetic nephropathy, diabetic neuropathy, diabetic retinopathy, coronary artery disease, myocardial infarction, peripheral arterial disease, stroke, sex hormones, estrogen, androgens, sex-specific risk factors, sex-specific treatment
MeSH terms
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Diabetic Nephropathies, Diabetic Retinopathy, Female, Humans, Male, Risk Factors, Sex Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.